Comments
Commented by Armin Schulz on November 12th, 2024 | 07:15 CET
Commerzbank, Thunder Gold, Plug Power – What happens after the US election?
After Donald Trump's commanding victory in the US election, the financial world faces a new era of economic transformation. In the midst of this changing political landscape, the markets are clearly identifying winners and losers. If the first term is anything to go by, banks will experience a boom due to deregulation measures and tax incentives, while the renewable energy sector will face new challenges. The rally in the price of gold has been slowed for the time being by a stronger dollar. On the other hand, interest rates continue to fall, making gold investments more attractive again. The return of Trump's economic policy agenda promises not only opportunities but also risks for sustainable investments. We look at one candidate from each area.
Read
Commented by Armin Schulz on November 12th, 2024 | 07:00 CET
Bayer, BioNxt Solutions, Novo Nordisk – Opportunities in the healthcare industry
In a market characterized by technological breakthroughs and the growing demand for innovative therapies, companies such as Bayer, BioNxt Solutions and Novo Nordisk offer exciting investment opportunities. While Bayer, a global pharmaceutical giant with a broad product portfolio, promises stability and long-term growth, BioNxt Solutions relies on highly specialized biotechnological innovations with disruptive potential. Novo Nordisk, a leading player in diabetes and metabolic disorders, is benefiting from the growing demand for solutions for chronic diseases. For investors looking to capitalize on trends in the healthcare industry, these three companies could make all the difference.
Read
Commented by Stefan Feulner on November 11th, 2024 | 07:30 CET
Bloom Energy, Almonty Industries, Barrick Gold – Strengthened for the year-end rally
Rarely has a trading week been more eventful than the past one. In addition to the landslide victory of the Republican presidential candidate Donald Trump, the traffic light coalition government is finally at a red light. The result was highly volatile and choppy trading. The high volatility is likely to continue until the end of the year, but the direction so far continues to point north.
Read
Commented by André Will-Laudien on November 11th, 2024 | 07:00 CET
Traffic light madness! The turnaround at BASF, Altech Advanced Materials, Nordex and Siemens Energy
The traffic light coalition departs – and the economy breathes a sigh of relief. Key future topics such as the energy transition, e-mobility and the energy storage market now have good prospects. With a redefinition of industrial policy in Germany, confidence is returning to small and medium-sized companies. With a constant stream of new regulations, high energy costs and excessive bureaucracy, the failed coalition had many things in mind – but not the economic well-being of Germany. A murmur is going through the fragile industrial complexes with the announced new election. We expect a surge of innovative ideas, especially in the areas of energy security and mobility. Check your portfolio!
Read
Commented by Juliane Zielonka on November 8th, 2024 | 07:00 CET
Myriad Uranium, Plug Power, RWE: New US policy creates winners and losers in the energy sector
Donald Trump's victory in the US presidential elections could lead to significant shifts in the global energy markets. While some market participants will have to reposition themselves, promising prospects are opening up for others. The Canadian explorer Myriad Uranium will benefit from the strategic realignment of US energy policy. The decision to ban the import of Russian uranium and the successful drilling results at the Copper Mountain project in Wyoming are excellent opportunities. Hydrogen specialist Plug Power, on the other hand, is experiencing a price decline of over 22% on NASDAQ – a possible indicator of the expected changes in funding policy. Global energy supplier RWE is attracting increased attention due to speculation surrounding the entry of the activist investor Elliott...
Read
Commented by André Will-Laudien on November 7th, 2024 | 07:45 CET
Trump triumphs! What happens now with gold, e-mobility and green tech? BYD, VW, Thunder Gold, Nel, and Plug Power in focus
The US election is over. Donald Trump is moving back into the White House. Along with a tougher stance on China, conservative voters in the US are hoping for a greater focus on their own country. America needs a complete renewal of its infrastructure and will push ahead with armaments, so commodities of all kinds will come into focus. For Europe, the degree of responsibility for its own affairs will increase significantly, and the development of stable supply chains is imperative. Trump supports Bitcoin, so gold may have to give up some of its recent gains. What are the yield or loss drivers for investors now? After the election, investors should separate the wheat from the chaff to ensure their portfolios are properly positioned.
Read
Commented by Armin Schulz on November 7th, 2024 | 07:30 CET
BASF, F3 Uranium, Super Micro Computer – Affordable energy is the key to corporate success
The huge appetite for energy at BASF, particularly for chemical production, must be met, as must the rapidly increasing demand for electricity from data centers using artificial intelligence. Renewable energies cannot yet fully meet this demand, as demand in the field of AI is likely to increase significantly in the coming years. Nuclear energy is an attractive option here, as it provides stable, large quantities of CO2-free energy and could thus efficiently serve both BASF and the increasing demands of AI data centers.
Read
Commented by Fabian Lorenz on November 7th, 2024 | 07:15 CET
TUI, Evotec, BioNxt Solutions: Short squeeze potential, Price drops, and Momentum
BioNxt Solutions' stock has gained 50% since the end of August. The chances are good that the momentum will continue for the biotech company. The stock would need to more than double to reach its January level. The industry environment is favorable, the news flow is positive, and takeover speculation exists. Takeover speculation is perhaps the only positive factor for Evotec's share at the moment. The operational development is certainly not. Yesterday, the Company reported a significant drop in earnings. Is there any improvement in sight? Operationally, TUI has been doing well for quite some time. With a jump in the share price, the stock is now setting its sights on the resistance at EUR 8. Could there even be a short squeeze? Analysts may also shift to the bull camp.
Read
Commented by Juliane Zielonka on November 7th, 2024 | 07:00 CET
Vidac Pharma, BioNTech, Bayer - Billion-Dollar Gene Therapy Market Attracts Investors
Two trends are emerging in the pharmaceutical industry: personalized medicine, which tailors therapies to the genetic profile of individual patients, and the development of highly specific active ingredients that target biological mechanisms. Vidac Pharma is one of the companies focusing on these targeted therapies and recently received a groundbreaking US patent for its innovative approach to normalizing cancer cell metabolism - a concept known as the "Warburg effect reversal." BioNTech is driving its transformation from COVID-19 vaccine producer to cancer specialist, with promising Phase II trials underway for treatments targeting lung and breast cancers. Bayer, meanwhile, is under pressure due to disappointing sales of its partner Regeneron's eye drug Eylea® – the second most important product in the portfolio, which has to hold its own against growing competition. Where is an investment worthwhile?
Read
Commented by André Will-Laudien on November 6th, 2024 | 08:00 CET
US election and the biotech sector – A hot November is on the cards! BioNTech, Pfizer, Nyxoah, Bayer or Evotec?
With anticipation building for both the Q3 earnings season and the US election results, the markets are in a wait-and-see mode. Democrat frontrunner Kamala Harris is said to be committed to continuing the successful policies of her predecessor Joe Biden. Of course, science, research and climate protection are in the spotlight. Her rival, Donald Trump, is said to be more concerned with strengthening the traditional economy, where automotive engineering, the defense industry and security companies come to the fore. Additionally, markets are looking to central banks for cues, as lower interest rates would be a boon for the biotech sector. Here are some investment ideas for dynamic investors in this promising climate.
Read